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Increased human longevity has magnified the negative impact that aging can have on cognitive integrity of older individuals experiencing some decline in cognitive function. Approximately 30% of the elderly will have cognitive problems that influence their independence. Impaired executive function and memory performance are observed in normal aging and yet can be an early sign of a progressive cognitive impairment of Alzheimer's disease (AD), the most common form of dementia. Brain regions that are vulnerable to aging exhibit the earliest pathology of AD. Senescent synaptic function is observed as a shift in Ca 2+ -dependent synaptic plasticity and similar mechanisms are thought to contribute to the early cognitive deficits associated with AD. In the case of aging, intracellular redox state mediates a shift in Ca 2+ regulation including N-methyl-d-aspartate (NMDA) receptor hypofunction and increased Ca 2+ release from intracellular stores to alter synaptic plasticity. AD can interact with these aging processes such that molecules linked to AD, ␤-amyloid (A␤) and mutated presenilin 1 (PS1), can also degrade NMDA receptor function, promote Ca 2+ release from intracellular stores, and may increase oxidative stress. Thus, age is one of the most important predictors of AD and brain aging likely contributes to the onset of AD. The focus of this review article is to provide an update on mechanisms that contribute to the senescent synapse and possible interactions with AD-related molecules, with special emphasis on regulation of NMDA receptors.
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Relationship between aging and Alzheimer's disease
Alzheimer's disease (AD) is the most common cause of dementia in older individuals, and is characterized by progressive memory loss and other cognitive impairments. According to the amyloid hypothesis of AD, ␤-amyloid (A␤) is the driving force for AD pathology [1, 2] . Indeed, a diagnosis of "pathological aging" due to AD, is defined by accumulation of A␤ in specific neuritic amyloid plaques, as well as neocortical neurofibrillary tangles of hyperphosphorylated tau and neuronal death. AD is observed in approximately 10 percent of the population of elderly over the age of 65. For a fraction of AD patients (∼1%), the generation and accumulation of A␤ is due to mutations in a few known genes including amyloid precursor protein (APP), presenilin-1 (PS1), and presenilin-2 (PS2). For these genes, a progressive cognitive decline begins around the fourth or fifth decade of life [3] [4] [5] . In contrast, most cases of AD exhibit a late-onset, emerging during the seventh decade. Indeed, the main risk factor for AD is age, suggesting a relationship between the mechanisms of aging and the onset and progression of AD. Normal aging is associated with selective changes in specific cognitive functions, particularly episodic memory which depends on the hippocampus [6, 7] . Importantly, the neural systems most vulnerable to AD pathology are the same systems that are susceptible to synaptic decline during aging, including the hippocampus [8] , such that weakening of hippocampal-dependent episodic memory is typically an initial cognitive deficit associated with normal aging and AD [9] [10] [11] [12] [13] . In the case of AD, intellectual deficits expand over time to disrupt executive function, semantic memories, language, and visuospatial abilities [14] . Thus, memory problems such as an increase in forgetting may be a sign of an age-related impairment of hippocampal synaptic transmission or an early indication of an evolving neurodegeneration [15, 16] . As such, much work has gone into developing cognitive tests that might be sensitive in differentiating benign forgetting of aging from neurodegenerative disease.
The evolution of cognitive decline from a memory deficit to clinical dementia may be linked to the progression of AD pathology. Plaques and tangles of AD are initially observed in the entorhinal cortex, progress to region CA1 of the hippocampus, and finally throughout the cortex [17] . This progression suggests regional vulnerability to AD. Considerable evidence now points to synaptic pathology as the mechanism for the initial memory deficits. Synaptic changes are present years prior to serious pathological neuronal degeneration and loss of synapse density in the hippocampus and cortex correlates well with disease progression [10, [18] [19] [20] . Indeed, the onset of impaired episodic memory is better characterized by neuroinflammation and synaptic loss in the hippocampus; while clinical dementia is more likely related to cell death and loss of connectivity throughout the brain [21] [22] [23] .
Animal models have been developed to study normal aging and AD related pathology. Aging rodents exhibit good face validity and construct validity for cognitive decline observed during normal aging in humans. Similar to aging humans, rapidly acquired hippocampal-dependent spatial episodic memory is sensitive to aging in rodents, with deficits emerging in middle-age and the probability of impairment increasing with advancing age [24] [25] [26] . There is no natural animal model of AD. In the absence of gene mutations, rodents normally do not develop neuritic amyloid plaques and neocortical neurofibrillary tangles [27] , suggesting that early cognitive deficits are due to aging of the hippocampal circuits involving senescent synaptic and cellular physiology. While impaired hippocampal-dependent episodic memory emerges early in rodent models, like AD, with advancing age cognitive deficits may progress to include multiple brain regions, manifesting as impairment in several behavioral domains including working or short term memory, associative and incremental learning of aspects of behavioral tasks that remain constant across trials, executive function, and global changes in stimulus reactivity [24, [28] [29] [30] .
Transgenic mice with AD-related genes, including the human apolipoprotein E4 (ApoE4) gene, APP, and PS1 mutations, have been developed to understand the pathogenesis of AD. Many of these AD mouse models also fall short in that a mutation in any one of the AD linked molecules does not produce the full spectrum of neuropathology including neocortical neurofibrillary tangles of hyperphosphorylated tau and neuronal death [31] . Rather, these mice may model early effects of soluble A␤ oligomers on synaptic function involving disruption of the same Ca 2+ signaling mechanisms that underlie impaired synaptic plasticity and memory during normal aging [32] . Even in the case of mice with multiple gene mutations that result in neurofibrillary tangles, altered synaptic function and impaired memory is observed before the manifestation of plaques and neurofibrillary tangles [33, 34] . In this case, it appears that AD-molecules acts on the processes associated with aging synapses prior to the appearance of tangles, plaques, and cell death.
What follows is a discussion of brain aging mechanisms, focusing on senescent synaptic function and the influence of ADrelated proteins on these processes. Our original senescent synapse hypothesis was based on the idea that Ca 2+ dysregulation during aging interacts with Ca 2+ -dependent synaptic plasticity mechanisms [35] . Evidence has accumulated to indicate that Ca 2+ influx through the N-methyl-d-aspartate (NMDA) receptor is decreased; such that Ca 2+ from other sources (i.e. internal Ca 2+ stores and voltage-gated Ca 2+ channels) exert greater influence on the direction and degree of synaptic plasticity [6, 24, 36, 37] . In the following sections, we describe recent findings that characterize the role of an age-related shift in redox state in regulating Ca 2+ from NMDA receptors and intracellular Ca 2+ stores (ICS) and the role of changes in NMDA receptors and ICS on synaptic plasticity and cognition. In addition, we discuss how the molecular mechanisms of AD interact with the process of senescent synaptic function to contribute to the early cognitive signs of AD.
The senescent synapse and altered synaptic plasticity
Hippocampal CA3-CA1 synapses are some of the best characterized synapses in terms of synaptic plasticity mechanisms and changes in synaptic plasticity are associated with aging and a decline in cognitive function. Long-term potentiation (LTP) and long-term depression (LTD) are two forms of activity-dependent synaptic plasticity that are intensely studied at CA3-CA1 synapses. LTP is an increase in synaptic transmission in response to high frequency stimulation. LTP induced at CA3-CA1 synapses by high frequency stimulation (e.g. 100 Hz) or theta burst stimulation is primarily dependent on NMDA receptors [38] [39] [40] . A high frequency stimulation of presynaptic fibers causes release of neurotransmitters, mainly glutamate, onto the postsynaptic cell membrane. The binding of glutamate to postsynaptic ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors triggers the influx of positively charged sodium ions into the postsynaptic cell and causes the cell to depolarize. The magnitude of depolarization determines the amount of Ca 2+ entry into the postsynaptic cell. If the degree of depolarization is sufficient to remove the Mg 2+ block of the NMDA receptor, then the channel will allow massive influx of Ca 2+ into the cell. The rapid rise in intracellular Ca 2+ concentration triggers the activation of several enzymes, specifically kinases, such as calcium/calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC), that mediate induction of LTP [41] . It is generally accepted that at CA3-CA1 hippocampal synapses, NMDA receptors provide the foremost source of Ca 2+ for LTP induction following stimulation frequencies near the threshold for synaptic modification [42, 43] . In contrast to the increase in synaptic transmission observed following induction of LTP, LTD is a long-lasting decrease in synaptic efficacy following low frequency stimulation. LTD induced at CA3-CA1 hippocampal synapses in younger animals by employing low frequency stimulation is dependent on the NMDA receptor [44] . Prolonged release of Ca 2+ in response to low frequency stimulation activates protein phosphatases, such as calcineurin, which dephosphorylates proteins and contributes to a sustained decrease in synaptic responses [36, 45, 46] . These mechanisms emphasize the role of NMDA receptor in mediating the strengthening and weakening of synaptic transmission in response to neural activity.
Over the course of aging there is a shift in CA3-CA1 hippocampal synaptic plasticity such that induction of LTP requires more intense neural activity, the decay rate for LTP is increased, and susceptibility to LTD is enhanced [6, 24, 36, 37] . Similarly, a decline in CA3-CA1 synaptic strength is associated with a modification in the balance of phosphatase/kinase activity that mimics decreased LTP and enhanced LTD [45, 46] . The shift in synaptic plasticity, like impaired episodic memory, can be observed in middle-age and the magnitude of LTP is correlated with cognitive deficits [24] . The relationship between age-related changes in the induction or decay of LTP and behavior appears to be specific to impaired acquisition or retention of episodic spatial memory [24, [47] [48] [49] [50] , since NMDA receptor-dependent LTP does not correlate with spatial reference memory [24, 51] . The increase in LTP decay rate for aged animals may be related to the increased susceptibility to induction of LTD. In older animals, the increase in LTD is correlated with enhanced forgetting after a single training session on the spatial version of the water maze [52] . The results are consistent with a body of evidence indicating that enhanced induction of LTD is associated with impaired memory following sleep deprivation [53, 54] , altered tumor necrosis factor ␣ signaling [55] , brain injury [56] , and stress [57] .
There is considerable evidence that molecular components of AD influence synaptic plasticity. Analogous to synaptic plasticity changes observed during aging, application of A␤ to hippocampal slices shifts synaptic plasticity, impairing induction of LTP, and increasing susceptibility to induction of LTD [58] [59] [60] [61] . The effects of APP mutants on LTP are variable and may depend on the level of A␤ expression, inclusion of other mutations including PS1, and the age of the animals. LTP impairments are more likely to occur in APP/PS1 double mutants and impairments may be revealed at a younger age [62] . Studies in aged animals indicate that the threshold for induction of LTD is reduced with advanced age at CA3-CA1 hippocampal synapses; however, similar asymptotic levels can be obtained by increasing the number of induction episodes or increasing the Ca 2+ /Mg 2+ ratio [52, [63] [64] [65] [66] . In the case of APP mutants, enhanced LTD is also observed, particularly when the pattern of stimulation is near the threshold for induction [61, 67, 68] . Similar to aging, when conditions are altered to maximize LTD [52, 64] ; no difference in LTD is observed in mutant mice [69] . Thus, like age-related effects, AD-molecules appear to interact with processes that regulate the threshold or duration of synaptic plasticity.
NMDA receptor dysregulation and brain aging
NMDA receptors are the major source of synaptic Ca 2+ involved in the rapid induction of synaptic plasticity. The activation of NMDA receptor requires binding of glutamate to the receptor and sufficient postsynaptic depolarization to remove the Mg 2+ block from the NMDA receptor channel. The necessity of pre-and postsynaptic activity underlies the associative nature of NMDA receptor activation. The associative properties, as well as long-duration, and synaptic specificity are characteristics that promote LTP and LTD as models of memory formation at the neuronal level.
Pharmacological studies and studies that employ mutant mice indicate that NMDA receptors are involved in trial-dependent spatial learning (i.e. episodic memory) [24] . There is substantial evidence indicating that NMDA receptor function is reduced with advancing age. In particular, the NMDA receptor component of synaptic transmission is decreased with age and the decrease correlates with impaired episodic memory [70] [71] [72] [73] . NMDA receptors are one of the most highly regulated receptors in the nervous system, such that a number of mechanisms could act alone or in combination to underlie the decrease in NMDA receptor mediated synaptic responses during aging.
Redox regulation
Oxidative stress increases with age and disease, and is thought to contribute to cognitive decline [74] . In addition to molecular damage induced by superoxide, a highly reactive oxygen species (ROS), the conversion of superoxide to the milder hydrogen peroxide can alter redox-sensitive signaling through the reversible formation of disulfide bonds [75] [76] [77] . NMDA receptor hypofunc- Similar to aging, several models of AD are associated with impaired induction or increased decay of LTP and enhanced susceptibility to induction of LTD. Furthermore, aging and models of AD exhibit a decrease in NMDA receptor mediated synaptic responses, which is thought to contribute to altered synaptic plasticity. During aging, NMDA receptor hypofunction results from a rise in oxidative stress (reactive oxygen species, ROS) and an oxidized redox state, involving oxidation to form disulfide bonds between cysteine pairs (SH SH → S-S) or oxidation of methionine to form methionine sulfoxide (S-CH3 → O = S-SH2) to alter Ca 2+ regulatory proteins including calmodulin (CaM) dependent protein kinase II (CaMKII) activity. In the case of several AD models, the rise in ␤-amyloid (A␤) oligomers is associated with reduced NMDA receptor function and several possible mechanisms have been proposed including an increase in oxidative stress (ROS), a decrease in CaMKII activity, NMDA receptor endocytosis, and direct effect on GluN2A and GluN2B NMDA receptor subunits. (NMDA EPSP)-NMDA receptor mediated excitatory postsynaptic potentials.
tion with advancing age is closely tied to redox state in the central nervous system (Fig. 1) . Oxidative stress has broad impacts on neuronal function, and can directly modify the structure or function of proteins by the oxidation of cysteine residues to form disulfide bonds between cysteine pairs [78, 79] . The introduction of oxidizing agents, including oxidized glutathione and xanthine/xanthine oxidase, reduces the NMDA receptor synaptic response in hippocampal slices from young relative to older animals, while bath application of the reducing agent dithiothreitol (DTT) enhances NMDA receptor synaptic responses specifically in older cognitively impaired animals [71] [72] [73] 76] .
The NMDA receptor contains three pairs of extracellular cysteine residues, and with increased oxidative stress, the cysteine residues may interact through the redox-mediated formation of disulfide bonds (Fig. 1) , altering receptor confirmation to decrease receptor function [78] [79] [80] [81] [82] . While this extracellular modification presents an attractive model of NMDA receptor impairment, our work indicates a primarily intracellular mechanism. Intracellular perfusion of membrane-impermeable reducing agent L-glutathione significantly enhances NMDA receptor responses, while bath application yields no effect [71] . The enhancement of NMDA receptor synaptic response by DTT is also blocked by inhibition of CaMKII, whose activity is increased by DTT in an age-dependent manner [71] . In this case, the results are consistent with an age-related oxidation of cysteine or methionine on intracellular Ca 2+ regulatory proteins including calmodulin [83, 84] . In turn, oxidation of calmodulin would limit CaMKII activation and CaMKII regulation of NMDA receptor function [71, 85] .
Several studies have linked a redox mediated NMDA receptor hypofunction with age-associated cognitive impairment. First, the decline in NMDA receptor mediated synaptic transmission and growth of the synaptic response following application of the reducing agent DTT, emerges in middle-age. Moreover, the magnitude of DTT-induced growth of the NMDA receptor mediated synaptic response at CA3-CA1 hippocampal synapses and medial prefrontal cortex synapses correlates with impaired spatial memory and executive function, respectively [72, 73, 76] . Finally, viral expression of superoxide dismutase diminished lipid peroxidation indicating superoxide contributes to oxidative damage [77] . However, expression of superoxide dismutase alone did not improve cognitive function and resulted in a DTT-sensitive decrease in the NMDA receptor mediated synaptic response [76] . The results suggest that superoxide dismutase converted superoxide to hydrogen peroxide, which would shift the redox state of the NMDA receptor. Indeed, viral expression of superoxide dismutase and catalase improved cognition and increased NMDA receptor synaptic responses, indicating that removal of hydrogen peroxide by catalase and subsequent reduced redox state was required [76, 77] . Together, the results provide evidence that redox sensitive signaling at the synapse, rather than the accumulation of oxidative damage, may be of greater significance in the emergence of agerelated learning and memory deficits.
NMDA receptors and Alzheimer's disease
One way that AD could interact with aging is through the NMDA receptor mechanism for senescence of synapses as proposed above (Fig. 1) . Mice that express mutated APP [34, 86] or ApoE4 [87, 88] exhibit a decrease in NMDA receptor mediated synaptic responses and impaired LTP. In mice, the decline in NMDA receptor function and synaptic plasticity is first observed in association with increased expression of A␤ oligomers, in the absence of prominent plaques [33, 34] . The idea that A␤ oligomers impair synaptic function is consistent with mounting evidence that the severity of AD is related to soluble A␤ oligomers [89] . In fact, A␤ application to neurons results in a rapid decrease in NMDA receptor responses due to NMDA receptor endocytosis and a loss of synaptic NMDA receptors [86, [90] [91] [92] . However, it is unclear if A␤-mediated NMDA receptor endocytosis represents the same redox sensitive mechanism observed to mediate NMDA receptor hypofunction in aging or represents a different and additive mechanism for reducing NMDA receptor function (Fig. 1) . Certainly, it has been suggested that AD-molecules increase oxidative stress [68, [93] [94] [95] , which could contribute to the redox mediated NMDA receptor hypofunction during aging. The redox sensitivity of NMDA receptors depends on CaMKII [71] and CaMKII is involved in the trafficking of glutamate receptors at the synapse [96, 97] . Interestingly, AD patients exhibit a decrease in synaptic CaMKII activity and treatment with A␤ decreased CaMKII synaptic activity in mice [98] . The mechanism for decreased CaMKII is unclear, though work in APP and PS1 mutant mice suggests a shift in Ca 2+ sources involving excess Ca 2+ from ICS [99, 100] . The level of CaMKII is reduced in APP transgenic mice and following A␤ oligomer treatment, and is associated with a decreased trafficking of AMPA receptors to the synapse [101] . In the case of NMDA receptors, it has been suggested that endocytosis due to A␤ and in APP mutants involves a shift in phosphatase/kinase activity and is specific to GluN2B NMDA receptor subunit [86, 90] .
Subunit regulation
The NMDA receptor is a hetero-tetramer consisting of two obligatory GluN1 subunits, and two modulatory GluN2 or GluN3 subunits [102] [103] [104] (Fig. 1) . The modulatory GluN2 subunit has several subtypes (GluN2A − GluN2D) that demonstrate unique spatial and temporal patterns of expression, as well as unique pharmacokinetic properties. In the mammalian forebrain, GluN2A and GluN2B predominate. Of particular interest, NMDA receptors bearing GluN2B subunits exhibit slower channel kinetics and larger Ca 2+ conductance. By taking longer to close, these channels allow more Ca 2+ influx into the cell over a longer period of time, and are therefore thought to be more conducive to the induction of activity dependent plasticity. GluN2B is expressed widely throughout the cortex and hippocampal formation, where levels are highest early in development before demonstrating a reduction in expression after the onset of sexual maturity [105] . Age-related decline in expression appears to be heterogeneous across species and brain regions, but this effect is robust in the hippocampus and prefrontal cortex, with several studies indicating an age-dependent decrease in GluN2B mRNA and protein expression [72, [106] [107] [108] [109] [110] [111] . Finally, a loss of GluN1, GluN2B, and possibly GluN2A subunits is observed in AD-patients [112] [113] [114] [115] [116] .
Studies that modify the expression of GluN2B support the idea that a decline in this subunit with aging contributes to cognitive decline. Mice lacking GluN2B exhibit impaired LTP and impaired hippocampal-dependent memory [117, 118] . Furthermore, upregulation of GluN2B significantly enhances LTP and memory function in rodents [119, 120] , including aged mice [121] . However, it is not clear from these studies if GluN2B is influencing development and acting as a form of biological reserve over the lifespan, possibly by forming more synapses. In a series of studies examining the mechanism for estradiol effects on memory, the results indicate that improved memory for older female rats was linked to an increase in synaptic NMDA receptor responses, mainly due to GluN2B [122] [123] [124] . Finally, studies using viral vectors to regulate GluN2B expression in adult animals have provided evidence that the level of GluN2B expression during aging is important for maintaining cognitive function [107, 125] .
One idea is that AD involves a rise in intracellular Ca 2+ due to NMDA receptor activation, which mediates the early decline in synaptic function and/or later toxicity and cell death. Therefore, considerable effort has gone into the investigation of the role of GluN2A and GluN2B in the A␤ induced impairment in synaptic function and apoptosis. Most of the work examining A␤ interactions with specific NMDA receptor subtypes has been performed in cell cultures or in acute brain slices. However, an in vivo study found that injection of A␤ into the brain impaired induction of LTP and the LTP impairment was reduced by specific blockade of GluN2B, but not GluN2A subunits [126] . Examination of direct effects of A␤ on activation of GluN2A and GluN2B receptors expressed in Xenopus oocytes indicates that A␤ does induce NMDA receptor activation, with much greater activation of GluN2A than GluN2B [127] . Using GluN2A and GluN2B specific antagonist, the effect of A␤ on intracellular Ca 2+ was examined in cortical cell cultures [128] . For a low dose of A␤, the rise in intracellular Ca 2+ was attenuated by the nonselective open channel blocker MK-801 and to a lesser extent by GluN2B blockade. In mouse hippocampal slice cultures, blockade of GluN2A prevented the A␤ mediated loss of dendritic spines [115] . In contrast, an interaction of A␤ with GluN2B may play a greater role in cell toxicity, inducing endoplasmic reticulum stress and neurodegeneration involving tau protein phosphorylation [115, 129] . Finally, the role of Ca 2+ in mediating altered synaptic function has recently been questioned. In this case, the A␤ induced decrease in synaptic transmission and spine loss could be blocked by the competitive receptor blocker APV or GluN2B selective antagonists Ro 25-6981 or ifenprodil, but not by open channel antagonist, MK-801 or ketamine, suggesting a metabotropic effect independent of Ca 2+ influx [130] [131] [132] .
Understanding the role of GluN2A and GluN2B in synaptic dysfunction and apoptosis of AD could have important repercussions for possible treatment of AD and age-related cognitive decline. The idea that cell death in AD is associated with over activity of NMDA receptors provides part of the basis for the use of the low affinity activity-dependent NMDA receptor antagonist, memantine, to treat AD. However, memantine has met with mixed success in treating memory impairments and the progression of neurodegeneration [133] . There are several possible explanations for the apparent lack of success. Due to the prominent role of NMDA receptors in memory, non-selective NMDA receptor open chan- 2+ from ICS and VDCCs acts on Ca 2+ -activated potassium channels, increasing potassium (K + ) efflux from the neuron and augmenting the amplitude of the afterhyperpolarization (AHP) in aged memory impaired animals and some models of AD. In turn, the membrane hyperpolarization further limits NMDA receptor activation altering synaptic plasticity. In the case of AD models, ␤-amyloid (A␤) and presenilin-1 (PS1) mutations can increase oxidative stress and increase release of Ca 2+ from ICS to augment the AHP amplitude and shift synaptic plasticity. (APs)-action potentials.
nel blockade may induce impairment of hippocampal-dependent memory. Indeed, memantime treatment can impair memory and effects of low level open channel blockade may be particularly evident in older individuals due to NMDA receptor hypofunction [134] [135] [136] . Furthermore, due to the activity-dependence, memantine is likely to have the greatest effect on the most active NMDA receptors, including those that maintain tonic inhibitory tone [137] . The loss of inhibitory tone could underlie memantine's proconvulsive effect [138, 139] . In this regard, it is important to note that seizure activity increases with AD [140, 141] and advancing age [142] . Animal models indicate that hyperexcitability can be observed in the oldest animals [143, 144] . Seizures can influence a wide network of neural systems involved in memory, disrupting processes such as semantic memory [145] in humans and reference memory in animals [146, 147] . Thus, NMDA receptor blockers could impair NMDA receptor-dependent episodic memory and if NMDA receptor hypofunction contributes to a loss of inhibitory tone, impairments could expand beyond episodic memory.
Intercellular Ca 2+ stores in aging and Alzheimer's disease
Another major source of intracellular Ca 2+ is through voltagedependent Ca 2+ channels and ICS. During the depolarization generated by an action potential, Ca 2+ enters through voltagedependent Ca 2+ channels and this Ca 2+ binds to ryanodine receptors (RyRs) to induce Ca 2+ release from ICS (Fig. 2) . The release of Ca 2+ from ICS is increased by oxidizing conditions due to the redox state of RyRs [148] . Furthermore, in hippocampal CA1 pyramidal cells, the shift in redox state during aging results in increased release of Ca 2+ from ICS [149] . The Ca 2+ from ICS acts on Ca 2+ -activated potassium channels in the membrane to hyperpolarize the neuron, augmenting the amplitude and duration of the spike driven afterhyperpolarization (AHP) [149, 150] . In turn, the membrane hyperpolarization further limits NMDA receptor activation [65, 150] . Thus, a shift in redox state mediates decreased Ca 2+ influx through NMDA receptors (Fig. 1) and an increased Ca 2+ release from ICS (Fig. 2) . In turn, the Ca 2+ from ICS augments the amplitude of the AHP, which further reduces activation of NMDA receptors to impair induction of LTP (Fig. 2) . Importantly, the role of ICS in synaptic plasticity is age sensitive. Similar to NMDA receptor hypofunction and impaired synaptic plasticity, an increase in the AHP is an early marker of impaired hippocampal-dependent learning [151] . In young animals, Ca 2+ from ICS facilitates induction of LTP [152, 153] ; however, during aging an increase in the AHP combined with NMDA receptor hypofunction raises the threshold for LTP induction in aged animals [150] . Indeed, the LTP impairment in aged animals can be ameliorated by treatments that reduce the AHP, permitting depolarization needed to activate NMDA receptors [65, 71, 150] .
In the case of A␤ application, a rise in intracellular Ca 2+ is thought to result from A␤ protein channels in the membrane, enhanced activity of voltage-gated Ca 2+ channels, and release of Ca 2+ from intracellular stores [154] [155] [156] [157] [158] [159] . Similar to aging, the rise in intracellular Ca 2+ from A␤ likely contributes to an A␤ mediated decrease in neuronal excitability by increasing the amplitude of AHP [160, 161] . The role of ICS in senescent physiology is highlighted by mice with mutant PS1. Mutation of the PS1 gene results in an elevation of Ca 2+ by promoting Ca 2+ release from internal stores. Similar to the effects of aging, the release of Ca 2+ due to PS1 mutation can act on K + channels to hyperpolarize neurons [162] [163] [164] . Thus, PS1 mutant mice exhibit an increase in the AHP [165] . Similar to the role of Ca 2+ release from ICS on synaptic plasticity with age, the effect of PS1 on LTP is age sensitive. In young mice with a PS1 mutation, the increase in Ca 2+ release from ICS likely contributes to an increase in the amplitude of LTP [166] [167] [168] [169] . In contrast, middle-age mutant mice exhibit impaired induction of LTP and the amplitude of LTP rapidly decays [170, 171] . The results emphasize that the molecular components of AD may act on the same processes that are dysregulated over the course of aging, which may explain why age is a major risk factor for the onset of AD.
This review has focused on hippocampal region CA1 and how AD-related molecules could interact with the early markers of aging to influence synaptic plasticity involved in episodic memory. Similar changes are likely at other aging and AD susceptible brain regions. For example, the entorhinal cortex is affected early in the course of AD and loss of entorhinal synaptic contacts on dentate gyrus granule cells has been noted in aging rodents, monkeys, and in AD patients [172] [173] [174] [175] [176] [177] [178] . Aged-memory impaired animals exhibit a decrease in NMDA-mediated perforant path to granule cell synaptic responses and impaired LTP [179, 180] . Similarly, A␤ mediated inhibition of perforant path to granule cell LTP may be due to an increase in oxidative stress [181] and dysregulation of Ca 2+ signaling [182, 183] , including the same Ca 2+ -dependent processes that regulate synaptic plasticity in hippocampal CA1 region [45, 184] . In normal aging, increasing the strength of remaining perforant path synaptic contacts may act as compensation to preserve cognition [174] . Again, it would appear that a compensatory increase in synaptic strength may depend on synaptic plasticity processes that are altered with age and may be compromised in AD. Finally, neurogenesis declines with age and the survival of granule cells likely depends on NMDA receptor activity [185] . It is important to note that redox state changes that mediate Ca 2+ dysregulation occur in middle-age in region CA1 and at medial prefrontal cortex synapses [72, 73] . Therefore, in the future, it will be important to map the time course and relationship of altered redox state and Ca 2+ dysregulation with senescent physiological changes for these other brain regions. Does NMDA receptor hypofunction of granule cells precede the loss of entorhinal input and impaired neurogenesis? Is NMDA receptor function of inhibitory cells compromised early, such that reduced tonic inhibition underlies the increase in hyperexcitability of principle cells in the cortex or hippocampal CA3 region [143, [186] [187] [188] ? Alternatively, is NMDA receptor hypofunc-tion a compensatory mechanism, which attempts to limit afferent hyperexcitability?
Conclusion
AD linked molecules appear to act on the same Ca 2+ dysregulation mechanisms that underlie impaired synaptic plasticity during aging. Specifically, A␤ and PS1 mutations promote hypofunction of NMDA receptors and increased release of Ca 2+ from ICS, which enhance the AHP, further impairing the ability to activate NMDA receptors. These early mechanisms of AD may explain why AD initially influences memory processes, which decline in normal aging and depend on NMDA receptor activity. Impaired synaptic plasticity and Ca 2+ dysregulation may subsequently influence transcription of survival genes [189] . Thus, the loss of transcription that maintains cell health combined with the rise in oxidative stress associated with aging could contribute to A␤ induced toxic effects and the progression of the disease. In order to understand the role of age as a risk factor for AD, future studies should determine whether redox state is a contributing factor to the onset of impaired synaptic plasticity in mutant mice.
